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Dysregulation of Ca2+ homeostasis is considered to contribute to the toxic action of
the Alzheimer’s disease (AD)-associated amyloid-β-peptide (Aβ). Ca2+ fluxes across the
plasma membrane and release from intracellular stores have both been reported to
underlie the Ca2+ fluxes induced by Aβ42. Here, we investigated the contribution of
Ca2+ release from the endoplasmic reticulum (ER) to the effects of Aβ42 upon Ca2+
homeostasis and the mechanism by which Aβ42 elicited these effects. Consistent with
previous reports, application of soluble oligomeric forms of Aβ42 induced an elevation
in intracellular Ca2+. The Aβ42-stimulated Ca2+ signals persisted in the absence of
extracellular Ca2+ indicating a significant contribution of Ca2+ release from the ER Ca2+
store to the generation of these signals. Moreover, inositol 1,4,5-trisphosphate (InsP3)
signaling contributed to Aβ42-stimulated Ca2+ release. The Ca2+ mobilizing effect of Aβ42
was also observed when applied to permeabilized cells deficient in InsP3 receptors,
revealing an additional direct effect of Aβ42 upon the ER, and a mechanism for induction
of toxicity by intracellular Aβ42.
Keywords: Alzheimer’s disease, Aβ oligomers, calcium/Ca2+, InsP3/IP3, InsP3 receptors/InsP3Rs, endoplasmic
reticulum/ER
INTRODUCTION
Alzheimer’s disease (AD) is a progressive and irreversible brain
disorder, which results in severe memory loss, behavioral as
well as personality changes and a decline in cognitive abili-
ties. While the most common type of AD remains idiopathic
in origin, with age the most significant risk factor for disease
onset (sporadic AD, sAD), ∼5% of cases show a Mendelian pat-
tern of inheritance (familial AD, fAD). The amyloid β-peptide
(Aβ) is hypothesized to be central to the pathogenesis of both
sporadic and familial AD (Hardy and Selkoe, 2002). Aβ is a
small, hydrophobic polypeptide, consisting of 39–42 amino acid
residues, which occurs principally as a 40 or 42 amino acid
peptide, Aβ40 and Aβ42, respectively (Zhang et al., 2011). An
imbalance between the production and clearance of Aβ, as occurs
in fAD and sAD, respectively, leads to the accumulation of Aβ
and, in turn, to its aggregation. This aggregation process rep-
resents a critical step in the pathogenesis of AD because the
neurotoxic properties of Aβ are associated only with aggregated
forms of the peptide (Kuperstein et al., 2010). Protein aggregation
is highly dynamic and involves a wide range of intermediate struc-
tures such as oligomers, comprising dimers, trimers, dodecamers,
and higher-molecular weight complexes, before aggregating into
protofibrils and finally into mature amyloid fibrils (Dobson,
2003).
A mounting body of evidence now suggests that soluble
oligomeric forms of Aβ constitute the primary neurotoxic species
rather than monomers or fibrils (Lambert et al., 1998; Chromy
et al., 2003; Gong et al., 2003; Demuro et al., 2005; Klyubin et al.,
2005). Soluble oligomers have proved toxic when applied to cul-
tured cells and primary neuronal cultures in vitro (Lambert et al.,
1998; Bucciantini et al., 2002; Dahlgren et al., 2002; Kayed et al.,
2003; Whalen et al., 2005). In addition, they are capable of induc-
ing cognitive deficits when administered in vivo (Cleary et al.,
2005; Rowan et al., 2007) and adversely affect hippocampal LTP
in vivo (Walsh et al., 2002; Cleary et al., 2005; Klyubin et al., 2009,
2011).
Dysregulation of intracellular Ca2+ homeostasis is associated
with cell exposure to Aβ and likely underlies its neurotoxic effects
(Bezprozvanny and Mattson, 2008; Green and Laferla, 2008;
Berridge, 2010; Demuro et al., 2010). A number of mechanisms
by which Aβ elicits its effects on intracellular Ca2+ homeostasis
have been put forward. These include direct effects on the plasma
membrane, where it has been proposed to destabilize its structure
(Mueller et al., 1995; Mason et al., 1996), to induce a general-
ized increase in membrane permeability (Bucciantini et al., 2002;
Kayed et al., 2003) or to insert into the membrane forming
cation-conducting pores (Arispe et al., 1993; Mueller et al., 1995;
Mason et al., 1996; Bucciantini et al., 2002; Kayed et al., 2003;
Kawahara, 2004; Simakova and Arispe, 2006; Arispe et al., 2007;
Demuro et al., 2011). Aβ has also been reported to activate plasma
membrane receptors, including N-methyl-d-aspartate (NMDA)
receptors coupled to Ca2+ influx (Guo et al., 1996; Dobson,
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2003; Blanchard et al., 2004; De Felice et al., 2007), to alter neu-
ronal excitability which, in turn, influences the extent of Ca2+
influx (Good et al., 1996) and to induce dysregulation of endo-
plasmic reticulum (ER) Ca2+ homeostasis (Ferreiro et al., 2004,
2006; Resende et al., 2008). In addition to acting from the extra-
cellular space, where it accumulates in the diseased brain, Aβ
also has an intracellular site of action (Wirths et al., 2004).
Indeed, as a result of uptake from the extracellular space or via
its intracellular synthesis and processing, Aβ has been reported
to accumulate within the cell (Pierrot et al., 2004; Bayer and
Wirths, 2011; Kaminski Schierle et al., 2011). This intracellular
Aβ is also neurotoxic and has been shown to target the ER and
the mitochondria, inducing a stress response and causing per-
meability transition, respectively (Yao et al., 2009; Umeda et al.,
2011).
In this study, we investigated (1) the contribution of Ca2+
mobilization from the ER to the increase in intracellular Ca2+
induced by oligomeric Aβ42, (2) the mechanism (s) by which
Aβ42 elicited this effect, (3) the capacity for Aβ42 to mobilize
Ca2+ directly from the ER. To allow isolation of effects on the ER
from other plasmamembrane targets of Aβ42, model cells systems
were used that allowed fundamental aspects of ER Ca2+ regu-
lation to be studied. We determined that Ca2+ release from the
intracellular ER substantially contributed to the increase in intra-
cellular Ca2+ concentration induced by oligomeric Aβ42. The
Aβ42-induced Ca2+ elevation comprised InsP3 dependent and
independent components. Using DT40 cells deficient in the three
InsP3R isoforms that were permeabilized to allow direct access
of Aβ42 to the ER, we also demonstrated that it had the capacity
to release Ca2+ from the ER independent of InsP3Rs. Together,
these data place the ER and Ca2+ released from it as central to
the actions of both extracellular Aβ and Aβ that has reached an
intracellular location.
MATERIALS AND METHODS
MATERIALS
Peptides were purchased from The American Peptide Company
and rPeptide. Cell culture reagents and chemicals were from
Invitrogen or Sigma, unless otherwise stated.
CELL CULTURE
Human neuroblastoma SH-SY5Y cells were cultured in F-
12 Nutrient Mixture (Ham) containing FBS (10%), penicillin
(100 units/ml), streptomycin (100μg/ml), non-essential amino
acids (0.1mM), and L-glutamine (2mM). Prior to all exper-
iments, SH-SY5Y cells were cultured overnight in Opti-MEM
Reduced Serum Medium, containing FBS (1.5%), penicillin
(100 units/ml), streptomycin (1.0μg/ml), non-essential amino
acids (0.1mM), and L-glutamine (2mM). For live-cell Ca2+
imaging experiments, cells were plated onto poly-L-lysine-coated
coverslips at a density of 3.2 × 104 cell/cm2. For the MTT reduc-
tion assay, cells were plated at a density of 9 × 103 cells/cm2.
To overexpress GFP-tagged type 1 InsP3 5′-Phosphatase (GFP-
5′P) or GFP (Peppiatt et al., 2004; Higazi et al., 2009), cells
were infected with adenovirus for 8 h prior to overnight culture.
Culture of DT40 cells and DT40 cells deficient in the three InsP3R
isoforms (DT40 TKO) was performed as previously described
(Tovey et al., 2006).
PREPARATION OF Aβ42 OLIGOMERS
Wild type and scrambled Aβ42 were obtained at a purity of>95%.
Peptide mass was verified by matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry and peptides
from the same batch were used throughout. Samples of synthetic
Aβ42 oligomers were prepared as previously described (Demuro
et al., 2005) and remained stable for at least 3 weeks. Samples
of Aβ1–42 scrambled peptide (KVKGLIDGAHIGDLVYEFMDSN
SAIFREGVGAGHVHVAQVEF) were prepared in the same way
as Aβ42 oligomers. All Aβ samples were stored at 4◦C and
were used within 10–15 days of preparation. Toxicity of Aβ42
preparations was confirmed by MTT assay before use in Ca2+
imaging experiments (Figure S1A). The oligomeric nature of the
Aβ42 preparation was established by surface plasmon resonance
(SPR) spectroscopy using an antibody specific to oligomeric Aβ42
(Figure S1B). All Aβ42 concentrations stated are based on the
molar mass of the peptide.
LIVE CELL Ca2+ IMAGING
Methods for single cell analysis of intracellular Ca2+ concen-
tration were as previously described (Peppiatt et al., 2003).
Cells were loaded at 37◦C with 2μM of the acetoxymethyl
(AM) ester form of fura-2 for 30min followed by an equivalent
period in dye free media to allow de-esterification of the indi-
cator. Imaging experiments were performed using either Ca2+-
containing (121mM NaCl, 5.4mM KCl, 0.8mM MgCl2, 1.8mM
CaCl2, 6mM NaHCO3, 25mM HEPES, 5.5mM glucose, pH
7.3) or Ca2+ free (as for Ca2+ containing with 1.8mM CaCl2
replaced with 1mM EGTA) buffer as indicated. Fura-2 imag-
ing was carried out using an imaging system configured around
a Nikon TE300 inverted epi-fluorescence microscope equipped
with a 20 × 0.75 NA multi-immersion objective. Samples were
illuminated by alternate excitation at 340 and 380 nm using a
Sutter filter changer (340HT15 and 380HT15; Sutter Industries)
and emitted light was filtered at >460 nm (1 ratio pair per
2 s). Images were captured using a Hamamatsu ORCA ER CCD
camera. The imaging system was controlled with Ultraview soft-
ware (PerkinElmer Life Sciences Ltd., UK). Acquired images were
processed with Ultraview software and analyzed in MATLAB.
Background subtracted fura-2 ratios were calibrated according to
standard procedures (Grynkiewicz et al., 1985), using the maxi-
mum and minimum ratio values obtained through exposing cells
sequentially to Ca2+ free and Ca2+ containing imaging buffer
to which 2μM ionomycin had been added. Parameters analyzed
from the Ca2+ responses included the peak amplitude, the time to
peak and the integral of the response (the area under the curve)
and the percentage of responding cells.
InsP3-induced Ca2+ release (IICR) from permeabilized wild
type and InsP3R null DT40 cells (three InsP3R isoforms deleted
by homologous recombination; DT40 TKO) (Sugawara et al.,
1997) was performed as previously described (Tovey et al., 2006).
Briefly, the ER of cells was loaded with the low-affinity Ca2+
indicator mag-fluo-4 and Aβ-induced Ca2+ release was measured
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from the saponin-permeabilized cells using a fluorescence plate
reader (FlexStation 3, Molecular Devices).
MTT REDUCTION ASSAY
The Cell Titer 96 Non-Radioactive Cell Proliferation Assay
(Promega) was used to validate the cytotoxic effect of Aβ42
on SH-SY5Y cells and was performed according to manufac-
turer’s instructions. Briefly, cells were incubated with Aβ42 (n =
4) for 24 h prior to the addition of the MTT dye solution and
a further 4 h incubation at 37◦C, 5% CO2. Thereafter, the sol-
ubilization/stop solution was added and incubated overnight at
room temperature. Absorbances were read at 570 nm with a ref-
erence wavelength of 650 nm using a fluorescence plate reader
(Synergy HT, BIO-TEK). The data is expressed as the percent-
age of MTT reduction relative to both live- and dead-cell controls
and thus represents the percentage of viable cells. Aβ42 samples
were considered to be toxic if 25–40% of cells remained metabol-
ically healthy at an Aβ42 concentration of 1μM and if more
than 50% remained metabolically healthy at a concentration of
100 nM.
STATISTICAL ANALYSIS
Data is presented as the mean value of the combined datasets ±
SEM. Statistical significance was determined by Student’s t-test
(two-tailed). Data was accepted as significant when p < 0.05 and
is denoted by ∗p < 0.05, ∗∗p < 0.01, or ∗∗∗p < 0.001.
RESULTS
INTRACELLULAR Ca2+ IS ELEVATED IN CELLS EXPOSED TO
OLIGOMERIC Aβ42
Experiments were first performed to validate the Ca2+ mobiliz-
ing properties of oligomeric Aβ42 over the concentration range
of its toxicity. Application of Aβ42 spanning its cytotoxic range
(1, 5 and 10μM) caused an elevation in intracellular Ca2+
(Figure 1A). The increase in cytosolic Ca2+ concentration imme-
diately followed the addition of Aβ42, developed to a peak
within minutes of application and subsequently returned to base-
line, despite the continued presence of the peptide. No Ca2+
responses were detected when Aβ42 below 1μM was applied
(data not shown). Between 1μM and 10μM Aβ, the number
of responding cells, the peak amplitude and the integral of the
Ca2+ responses increased in a concentration-dependent man-
ner. The number of responding cells reached 100% at 5μM
Aβ42 (Figures 1Bi,iii,v). To test cell viability as well as to deter-
mine whether metabotropic Ca2+ signaling was affected by Aβ,
carbachol (CCH) was applied subsequent to Aβ. CCH elicited
Ca2+ responses in 100% of cells pre-exposed to 1 or 5μM
oligomeric Aβ42 or to a vehicle control (10%) (Figures 1Bii,iv,vi).
At 10μM Aβ, however, the number of cells responding to
CCH was significantly reduced (Figure 1Bii). The peak ampli-
tude and integral of the Ca2+ responses to CCH subsequently
applied were inversely related to the magnitude of the Ca2+
responses elicited by oligomeric Aβ42 (Figures 1Biv,vi). This
observation suggested that exposure to Aβ42 oligomers was
depleting the intracellular CCH-sensitive ER Ca2+ store. These
Ca2+ mobilizing effects of oligomeric Aβ42 were significantly
greater than observed in cells exposed to Aβ42 that had been
prepared in a manner to yield a monomeric form of the pep-
tide (Figures S2, S1B). From these results, due to its potency
in mobilizing Ca2+ whilst preserving agonist responses, a con-
centration of 5μM oligomeric Aβ42 was selected for use in
subsequent experiments.
Aβ42 OLIGOMER-INDUCED Ca2+ TRANSIENTS ARE PEPTIDE
SEQUENCE SPECIFIC
As a control for the application of peptide, experiments were
also performed using a scrambled Aβ sequence, which had been
prepared in the same manner as the wild type Aβ42. Although
significantly less toxic than the wild type sequence (Figure S1A),
scrambled Aβ peptide also evoked Ca2+ responses in all cells
(Figure 2Ai). However, consistent with its lower toxicity, both
the amplitude and the integral of the Ca2+ transients elicited
by scrambled Aβ were significantly lower than those induced by
oligomeric Aβ42 and, in addition, they required a significantly
longer time to reach peak (Figures 2Bi,Ci,Di). Furthermore, con-
cordant with the less potent effect of scrambled Aβ in mobilizing
intracellular Ca2+, the amplitude and integral of CCH-induced
Ca2+ transients elicited following prior exposure to scrambled Aβ
were significantly greater than those stimulated following prior
exposure to oligomeric Aβ42 (Figures 2Bii,Cii,Dii).
Taken together, the comparison of the effects of Aβ scramble
and oligomeric Aβ42 demonstrates that the amino acid sequence
of Aβ42 has potent Ca2+ mobilizing properties, which are distinct
from the action of Aβ scramble.
Aβ42 OLIGOMERS MOBILIZE Ca2+ FROM INTRACELLULAR STORES
The reduced magnitude of CCH-induced Ca2+ signals observed
in cells previously exposed to oligomeric Aβ42 suggested that this
form of Aβ42 was exerting an effect on intracellular Ca2+ stores.
Therefore, we tested the relative contributions of Ca2+ influx
from the extracellular space and its release from intracellular
stores to Aβ42-induced Ca2+ transients.
To determine the contribution of extracellular Ca2+ and Ca2+
influx to Aβ42 oligomer-induced Ca2+ transients, we performed
experiments using Ca2+-free imaging buffer. Under these con-
ditions, Aβ42 oligomers retained their ability to induce Ca2+
responses, with 100% of cells responding (Figure 3Ai). While
no significant difference was observed in the peak amplitude
(Figure 3Aiii) of Aβ42 oligomer-induced Ca2+ transients, the
integral of the response was significantly decreased in the absence
of extracellular Ca2+ (Figure 3Av).
In contrast to the Aβ42 oligomer-induced Ca2+ response,
the peak amplitude and the integral of the Ca2+ responses to
CCH applied following Aβ42 oligomer exposure were significantly
decreased by removal of extracellular Ca2+ from the imaging
buffer (CCH, after Aβ42; Figures 3Aiv,vi). This effect on the
CCH-induced Ca2+ responses is likely due to lack of store-
operated Ca2+ entry, which would replenish the Ca2+ released
from stores by Aβ42. Indeed, the peak amplitude and the inte-
gral of CCH-induced Ca2+ responses elicited in Ca2+ free buffer
were significantly greater in naïve cells (CCH, no Aβ42) than when
Aβ42 oligomers were previously applied (Figures 3Aiv,vi). Since
Aβ42 oligomer-induced Ca2+ transients were not significantly
affected by removal of extracellular Ca2+, these results suggest
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FIGURE 1 | Aβ42 oligomers induce Ca2+ transients in a
concentration-dependent manner. (A) Example fura-2 Ca2+ traces of
SH-SY5Y cells exposed to a concentration range of Aβ42 oligomers followed
by 100μM CCH. A trace taken from cells in which Aβ42 oligomers were
substituted with double-distilled water (dd H2O; vehicle) is also shown (for
each group, n > 744 cells). (B) Quantitative analysis of the Ca2+ responses
illustrated in A. The magnitude of Ca2+ responses elicited by Aβ42 oligomers,
dd H2O and CCH is presented as (Bi,ii) percentage of responding cells,
(Biii,iv) peak amplitude and (Bv,vi) integral of the response. Aβ42
oligomer-induced Ca2+ transients were normalized to the responses induced
with the highest concentration (10μM) of the respective Aβ42 preparation.
CCH-induced Ca2+ responses were normalized to control experiments
conducted on the same experimental day. Bar graphs are mean ± SEM from
at least three independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
FIGURE 2 | Aβ42 oligomer-induced Ca2+ transients are sequence
specific. Bar charts illustrating the magnitude of Ca2+ responses
elicited by SH-SY5Y cells following the application of 5μM Aβ42
oligomers or Aβ scramble and 100μM CCH (n > 370 cells). Data
is presented as (A) percentage of responding cells, (B) peak
amplitude, (C) integral of the response, (D) time to peak. Bar
graphs are mean ± SEM from at least three independent
experiments. ∗∗∗p < 0.001.
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FIGURE 3 | Aβ42 oligomer-induced Ca2+ transients arise through release
from the ER Ca2+ store. Bar charts illustrating the magnitude of Ca2+
responses elicited following the manipulation of (A) extracellular (n > 218
cells) and (B) ER Ca2+ concentrations (n > 512 cells). The magnitude of Ca2+
responses elicited by 5μM Aβ42 oligomers and 100μM CCH is presented as
(i,ii) percentage of responding cells, (iii,iv) peak amplitude and (v,vi) integral
of the response. Bar graphs are mean ± SEM from at least three
independent experiments. ∗∗∗P < 0.001.
that oligomeric Aβ42 and CCH mobilize Ca2+ from a common
intracellular Ca2+ pool.
The requirement of Ca2+ release from the ER Ca2+ store for
the Ca2+ transients elicited by Aβ-induced was next investigated.
To this end, ER Ca2+ stores were depleted by exposure of cells
the SERCA pump inhibitor thapsigargin (Tg; 2μM, 15min) prior
to the application of Aβ42. In the absence of replete ER Ca2+
stores, Aβ42-induced Ca2+ transients were completely abrogated
(Figures 3Bi,iii,v). Similarly, CCH-induced Ca2+ responses were
eliminated in Tg-treated cells (Figures 3Bii,Biv,Bvi), confirming
the effect of Tg. Taken together, these experiments establish that
Aβ42 oligomers mobilize Ca2+ from the ER.
Aβ42-INDUCED Ca2+ RELEASE OCCURS IN PART THROUGH INSP3Rs
Having determined that Aβ42 oligomers mobilize Ca2+ from the
intracellular ER Ca2+ store, we aimed to identify the mecha-
nism by which Ca2+ release occurs. We therefore tested whether
Aβ42 was causing Ca2+ release from the ER through activation
of InsP3R or ryanodine receptor (RyR) Ca2+ release channels
localized to this organelle.
Although SH-SY5Y cells have been reported to express func-
tional RyRs, application of caffeine (10mM), an agonist of the
three RyR isoforms (10mM) did not elicit a Ca2+ response in
the SH-SY5Y cells used in this study (Figure S2A). Furthermore,
the neuronally-expressed type 2 RyR could not be detected by
immunoblot analysis (Figure S2B). Based on these observations,
a role for RyR2 in Aβ42 oligomer-mediated Ca2+ release was ruled
out.
SH-SY5Y cells express InsP3Rs and elicit robust Ca2+
responses to InsP3-generating agonists including CCH (Tovey
et al., 2001) (Figures 1–3). Therefore, we focused our investi-
gation on the contribution of InsP3Rs to Aβ42-induced Ca2+
transients. To abrogate InsP3-mediated Ca2+ responses, InsP3
signaling was inhibited pharmacologically with 10mM caf-
feine (Parker and Ivorra, 1991; Bezprozvanny et al., 1994) or
was prevented by adenoviral-mediated overexpression of GFP-
5′P, which metabolizes the second messenger InsP3 to inac-
tive InsP2 (Higazi et al., 2009). To exclude the contribu-
tion of Ca2+ influx to the Aβ42 oligomer-induced Ca2+ tran-
sients, these experiments were performed in the absence of
extracellular Ca2+.
Caffeine application did not affect the number of cells exhibit-
ing Ca2+ responses following Aβ42 oligomer application, with
100% of cells responding (Figure 4B). However, caffeine signif-
icantly decreased the peak amplitude and the integral of the Aβ42
oligomer-induced Ca2+ transients (Figure 4B). In contrast, Aβ
scramble-induced Ca2+ transients were unaffected by caffeine
application (Figure 4C). Ca2+ responses to 0.5μM CCH were
abolished by caffeine, demonstrating its inhibitory effect upon
IICR (Figures 4A–C).
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FIGURE 4 | Aβ42 oligomer-induced Ca2+ release is sensitive to caffeine.
(A) Imaging protocol employed to investigate the involvement of InsP3Rs in
Aβ42 oligomer-mediated Ca2+ release from the ER. InsP3Rs were inhibited by
co-administration of caffeine. (B,C) Bar charts illustrating the magnitude of
Ca2+ responses elicited by SH-SY5Y cells following the application of 5μM
Aβ42 oligomers (n > 780 cells) (B) or Aβ scramble (n > 144 cells) (C) and
0.5μM CCH (n = 512 cells) in the presence or absence of 10mM caffeine.
Data is presented as percentage of responding cells, peak amplitude and
integral of the response. Bar graphs are mean ± SEM from at least three
independent experiments. ∗∗∗P < 0.001.
Although caffeine inhibits InsP3Rs (Bezprozvanny et al.,
1994), it also acts on targets other than the InsP3R such as
cyclic nucleotide phosphodiesterases and phospholipase C (PLC)
(Toescu et al., 1992; Taylor and Broad, 1998). Therefore, to inves-
tigate further the role of InsP3 signaling in the generation of Aβ42
oligomer-induced Ca2+ transients, InsP3 signaling was inhibited
by GFP-5′P overexpression. Using this strategy, InsP3-mediated
Ca2+ signals induced by CCH were prevented, validating this
approach for suppression of InsP3 signaling (Figure 5A). As
observed for caffeine, however, GFP-5′P overexpression did not
prevent Aβ42 oligomer-induced Ca2+ transients, with 100% of
cells responding (Figure 5B). However, the peak amplitude and
the integral of Aβ42 oligomer-induced Ca2+ transients were sig-
nificantly decreased by overexpression of GFP-5′P (Figure 5B)
when compared to the magnitude of Ca2+ transients in control
cells, expressing GFP alone. Significantly, Aβ scramble-induced
Ca2+ transients were not affected by GFP-5′P overexpression with
no significant impact of its expression upon the peak ampli-
tude or the integral of Aβ scramble-induced Ca2+ transients
(Figure 5C). Taken together, these results demonstrate that Ca2+
transients elicited by Aβ42 oligomers arise as a result of release
from the ER intracellular Ca2+ store and that activation of
InsP3Rs contributes to this effect.
Aβ42 OLIGOMER-INDUCED Ca2+ LEAK FROM THE ER
The data presented above indicates that externally applied Aβ42
rapidly induces an increase on cytosolic Ca2+ that involves
InsP3-dependent and -independent Ca2+ release from the ER.
Since Aβ42 has also been shown to elicit some of its cytotoxic
effects as a result of intracellular accumulation (Wirths et al.,
2004), we investigated whether it mobilized Ca2+ from the ER
when directly applied. We also tested whether InsP3Rs were
required for its intracellular action.
To this end, an established permeabilized cell high-throughput
functional assay of ER Ca2+ release was used (Tovey et al., 2006).
This model uses as substrate for specific analysis of ER Ca2+
release, a plasma membrane-permeabilized preparation of the
DT40 chicken B-lymphocyte cell line. A derivative of this cell
line in which the 3 InsP3R isoforms have been deleted by homol-
ogous recombination (DT40 TKO), allows the requirement for
InsP3Rs for Ca2+ release to be tested (Sugawara et al., 1997). Cell
permeabilization and substantial dilution in intracellular buffer
rules out the contribution of endogenously generated InsP3 to
signaling in this assay. Using this assay, a significantly greater
InsP3 independent ER Ca2+ leak was observed in both wild-type
(p = 0.002) and DT40 TKO cells (p = 0.0195) exposed to Aβ42
oligomers compared to the passive Ca2+ leak detected in each
cell type (Figures 6A,B). The maximal Ca2+ leak rate induced
by Aβ42 oligomers was not significantly different between wild-
type and DT40 TKO cells (p = 0.2606, Figure 6C), suggesting
that InsP3Rs were not required for Aβ42 oligomers to trigger Ca2+
release.
Aβ scramble did not increase the rate of the Ca2+ leak in DT40
cells (p = 0.2528) or in DT40 TKO cells (p = 0.0993) compared
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FIGURE 5 | Aβ42 oligomer-induced Ca2+ release occurs is reduced by
InsP3 5′P expression. (A) Imaging protocol employed to investigate the
involvement of InsP3Rs in Aβ42 oligomer-mediated Ca2+ release from the ER.
InsP3 was metabolized by overexpression of InsP3 5′P. (B,C) Bar charts
illustrating the magnitude of Ca2+ responses elicited by SH-SY5Y cells
infected with InsP3 5′P or GFP alone following the application of 5μM Aβ42
oligomers (n > 207 cells) (B) or Aβ scramble (n > 115 cells) (C) and 0.5μM
CCH (n > 55 cells). Data is presented as percentage of responding cells,
peak amplitude and integral of the response. Bar graphs are mean ± SEM
from at least three independent experiments. ∗P < 0.05.
to the passive Ca2+ leak observed in each cell type (Figure 6B),
and thus there was no significant difference in the maximal Ca2+
leak rate following Aβ scramble application between these two cell
types (p = 0.2522, Figure 6C). Importantly, a significant differ-
ence between the Ca2+ leak rates triggered by exposure to Aβ42
oligomers and Aβ scramble in wild-type DT40 cells (p = 0.0056)
and DT40 TKO cells (p = 0.0045) was observed, indicating that
Aβ-induced Ca2+ leak from the ER is dependent and specific to
the amino acid sequence of Aβ42. Taken together, these results
suggest that Aβ42 oligomers trigger a Ca2+ leak from the ER,
which does not depend upon a direct interaction with InsP3Rs.
DISCUSSION
Here we show that the oligomeric form of the AD-associated pep-
tide Aβ42 has potent Ca2+ mobilizing properties and we identify
mechanisms responsible for its action. Using both intact and per-
meabilized cell assays to investigate the effects of extracellular
and internalized Aβ42, respectively, we establish that Ca2+ release
from the ERmakes the greatest contribution to the Ca2+ mobiliz-
ing effects of Aβ42. The InsP3 signaling pathway also contributes
to the Ca2+ mobilizing properties of oligomeric Aβ42 in intact
cells. InsP3Rs were not required for Aβ42-stimulated Ca2+ flux
in permeabilized cells ruling out a direct regulation of InsP3Rs
by Aβ42.
Central to the Ca2+ hypothesis of amyloid toxicity is the prop-
erty of Aβ to induce Ca2+ elevations in its target cells. This sets
in motion a cascade of events, which culminates in neuronal
death. Ever since this hypothesis was put forward more than 20
years ago (Khachaturian, 1989, 1994), numerous reports have
described Aβ-induced changes in intracellular Ca2+ in a num-
ber of cell types including primary neurons and astrocytes as
well as neuroblastoma cell lines (Abramov et al., 2004b; Demuro
et al., 2005). While there is general consensus that Aβ affects
Ca2+ homeostasis, the mechanisms underlying this action of
Aβ are many. Contributing to this diversity are the different
experimental models used, the peptide sequence applied, the con-
formational state of the peptide and the method used for peptide
preparation. Indeed, a number of shorter Aβ sequences have
been employed in in vitro studies and depletion of ER Ca2+
store content reported (Ferreiro et al., 2004, 2008). Since Aβ42
is considered to be more relevant to the pathology of AD, we
focused on its effects on intracellular Ca2+ homeostasis. Not
only is an accumulation of Aβ42 observed in AD, this longer and
more hydrophobic peptide is also more prone to self-assemble
than Aβ40, the other principle length at which Aβ occurs. As
a result, Aβ42 exerts a greater degree of neurotoxicity (Jarrett
and Lansbury, 1993). Consistent with the growing body of evi-
dence that soluble oligomeric forms of Aβ constitute the primary
neurotoxic species (Walsh et al., 2002; Gong et al., 2003; Cleary
et al., 2005; Klyubin et al., 2005), this species of Aβ42 potently
induced Ca2+ fluxes and cytotoxicity in this study (Figures 1, 2
and Figure S2). Highlighting the requirement for appropriate
peptide controls when studying Aβ42, Ca2+ release and cyto-
toxicity was also induced by a scrambled peptide sequence of
Aβ42, although the magnitude of these responses was significantly
lower than that induced by the wild type sequence. From these
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FIGURE 6 | Aβ42 oligomers stimulate Ca2+ release from the ER of
permeabilized cells. (A) Representative traces of mag-fluo-4 fluorescence
(relative fluorescence units, RFU) in permeabilized DT40 cells and DT40
TKO cells, illustrating changes in ER luminal Ca2+ levels as a function of
time in response to Aβ42 oligomers, Aβ scramble and buffer alone. Data
represents the mean of three measurements. (B,C) Initial quantitative
analysis of the maximum Ca2+ leak rates from the ER of permeabilized
DT40 cells and DT40 TKO cells triggered by Aβ42 oligomers, Aβ scramble
and buffer, respectively. The maximal Ca2+ leak rate was calculated by
taking the maximal value of the first derivative of the fluorescence values to
the time. Data were calculated as −dF/dt and represents the mean Ca2+
leak rate obtained from three measurements in RFU over time (RFU/s).
∗∗p < 0.01.
results, we concluded that the peptide sequence of Aβ42 was the
major contributor to the toxicity and Ca2+ mobilizing proper-
ties. The temporal properties of the Ca2+ transients we observed
were reminiscent of those reported elsewhere, being relatively
slow in reaching peak and returning to baseline levels after a few
minutes (Demuro et al., 2005; Simakova and Arispe, 2006). The
return of these Ca2+ signals to baseline does, however, suggest
that the Ca2+ elevations induced by Aβ42 were not immedi-
ately toxic. The Ca2+ mobilizing properties of the scrambled
peptide, however, may reflect the previously described intrinsic
properties of an oligomeric/amyloid peptide (Bucciantini et al.,
2002; Yoshiike et al., 2008). For example, oligomeric forms of
polyQ and insulin have been shown to induce Ca2+ transients
(Demuro et al., 2005). The solvent HFIP used for preparation of
the peptide has also previously been shown to exhibit cytotoxic-
ity and to affect ion conductance of membranes (Capone et al.,
2009).
Both Ca2+ influx from the extracellular space and release from
ER-localized intracellular stores have been reported to be induced
by Aβ and involved in its toxic action (Blanchard et al., 2004;
Ferreiro et al., 2004, 2006; Kayed et al., 2004; Demuro et al., 2005,
2011; Kelly and Ferreira, 2006; Simakova and Arispe, 2006; Arispe
et al., 2007; De Felice et al., 2007; Resende et al., 2008; Demuro
and Parker, 2013). Although Ca2+ entry from the extracellular
space was a component of the Ca2+ elevation induced by Aβ42
in this study, the greatest contribution was due to release from
the ER. Moreover the lack of an effect of removal of extracellular
Ca2+ upon the initial peak of the Ca2+ response or the number
of responding cells suggested that Ca2+ entry across the plasma
membrane was secondary to Ca2+ release from the ER. Since Aβ42
was acting to deplete the ER stores, the Ca2+ influx could arise via
a store-operated Ca2+ entry pathway. These observations are not,
however, incompatible with an additional mechanism for Ca2+
entry via plasma membrane pores formed by Aβ42, which have
been shown to require a longer period to develop (Demuro et al.,
2011). Whether the Ca2+ fluxes associated with the formation
of membrane pores, which were generally local to the pore and
were of a relatively small magnitude, contribute to the global Ca2+
transient is not clear (Demuro et al., 2011).
Analysis of the mechanisms underlying Ca2+ release from
the ER revealed that while InsP3Rs contributed to Aβ42-induced
Ca2+ release from the ER in intact cells, the greater part of
the Ca2+ elevation induced by Aβ42 was due to an alterna-
tive mechanism. However, IICR did not contribute to the Ca2+
responses induced by scrambled peptide. From these results, we
concluded that Aβ42-induced Ca2+ release from the ER comprises
an Aβ42 sequence-specific component, which is InsP3-dependent,
and a second component, which is peptide sequence- and InsP3-
independent. Comparison of these Aβ42 and Aβ42 scrambled
datasets reveals that although the InsP3-dependent component of
the total Aβ42 signal is relatively minor, when considered as a frac-
tion of the Aβ42-specific Ca2+ signal (i.e., Aβ42—Aβ42 scrambled
Ca2+ transient), its importance is increased.
Our demonstration of the participation of InsP3 signaling
in Aβ42-induced Ca2+ responses provides robust evidence in
support of this pathway in Aβ42-mediated Ca2+ signals thus
far. In particular, the use of InsP3 5′phosphatase overexpres-
sion to suppress InsP3 signaling is a highly selective strategy,
overcoming issues regarding incomplete knockdown of InsP3Rs
and contribution of the isoforms not targeted when using
siRNA approaches. The inhibition of Ca2+ signals by caffeine
is also consistent with a role for the InsP3 signaling path-
way in the Ca2+ mobilizing effects of Aβ (Parker and Ivorra,
1991; Bezprozvanny et al., 1994). Not only does caffeine inhibit
InsP3Rs directly (Bezprozvanny et al., 1994), by also inhibiting
PLC, caffeine is a potent inhibitor of InsP3 generation (Taylor
and Broad, 1998). These findings are consistent with the reduc-
tion in the Aβ42-induced Ca2+ transient observed following
application of the PLC inhibitor U73122 (Resende et al., 2008)
although U73122 has numerous non-specific effects. The mech-
anism by which InsP3 signaling is engaged by Aβ42 in this
study remains to be established. Since the effects of inhibition
of InsP3 signaling persist in the absence of extracellular Ca2+,
activation of PLC and InsP3 generation by Aβ42-stimulated Ca2+
influx can be excluded. Thus, a more likely scenario would
involve Aβ42 engagement of a PLC-coupled G protein coupled-
receptor (GPCR). Indeed, a number of different GPCRs, includ-
ing metabotropic glutamate receptors, are activated by Aβ42,
contributing to modulation of LTP, Aβ42 synthesis and processing
and cytotoxicity (Wang et al., 2004; Thathiah and De Strooper,
2011).
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The internalization of Aβ from the extracellular space
(Bucciantini et al., 2004; Pierrot et al., 2004; Wirths et al., 2004;
Kaminski Schierle et al., 2011) raises a further possibility that
Aβ acts to either directly activate/sensitize InsP3Rs or to alter
InsP3 generation/metabolism. Since significant intracellular Aβ42
accumulation would require up to 1 h (Bucciantini et al., 2004;
Kaminski Schierle et al., 2011), it is unlikely that this endocy-
tosed Aβ42 contributes to the acute modulation of Ca2+ fluxes
observed in this study and elsewhere in intact cells. Endocytosis
of Aβ42 may, however, contribute to the more chronic effects
on Ca2+ homeostasis as well as cytotoxicity previously reported
(Ferreiro et al., 2004, 2006; Resende et al., 2008). The possibil-
ity that Aβ42 could directly affect ER Ca2+ homeostasis from
an intracellular location was therefore also considered. Using a
permeabilized cell assay to allow control of cytosolic conditions
and access of Aβ42 to the ER, an Aβ42-stimulated Ca2+ efflux
from the ER was observed. Unlike that observed for intact cells,
the difference between Aβ42 and Aβ42 scrambled was dramatic,
revealing a highly specific effect of Aβ42 upon ER Ca2+ mobi-
lization. These effects were observed in the absence of exogenous
InsP3 suggesting that the effects were InsP3R-independent. The
extensive dilution of cytosol following permeabilization of the
DT40 cells would also likely preclude a contribution of Aβ42-
stimulated InsP3 generation. More significantly, InsP3Rs were
not required for the Ca2+ mobilizing properties of Aβ42, since
deficiency in all three InsP3R isoforms did not affect the Ca2+
mobilizing properties of Aβ42. The absence of a requirement for
InsP3Rs for Aβ42-stimulated Ca2+ flux in the permeabilized cell
system does not rule out the possibility that IICR contributes to
Ca2+ fluxes and toxicity mediated by intracellular Aβ42. Indeed,
by activating Ca2+-sensitive PLC and generation of InsP3, Ca2+
mobilized by Aβ42 could promote IICR. Consistent with this
notion, microinjected Aβ42 was recently shown to promote Ca2+
signals in Xenopus oocytes in a manner that involved InsP3
generation (Demuro and Parker, 2013).
The depletion of the ER Ca2+ store by Aβ42 has important
implications for the mechanisms of its toxicity. Depletion of ER
Ca2+ stores results in the accumulation of unfolded proteins
and activation of the ER stress response, which via caspase 12
activation and Bap31 cleavage can subsequently induce mito-
chondrial apoptotic cascades (Verkhratsky, 2005; Xu et al., 2005;
Mekahli et al., 2011). The engagement of InsP3Rs during Aβ42-
stimulated depletion of ER Ca2+ may be of greater consequence.
Specifically, InsP3R-induced Ca2+ release from the ER and its
subsequent sequestration by neighboring mitochondria could
lead to mitochondrial Ca2+ overload, permeability transition and
death (Csordas et al., 2006). These pathways also lead to increased
reactive oxygen species generation, which is commonly observed
in AD (Ferreiro et al., 2004, 2008; Arduino et al., 2009; Clark et al.,
2010).
The use of SH-SY5Y neuroblastoma cell line and permeabi-
lized DT40 B-lymphocytes in this study, rather than primary
neurons allowed careful dissection of the role of ER Ca2+ signal-
ing to Aβ-induced Ca2+ signals independent from Ca2+ fluxes
that may arise in neurons as a result of electrical or synaptic
activity. Moreover, using this cell line, contributions from other
Aβ targets described in neurons such as NMDA receptors are
excluded. Analogous to a number of other studies in electri-
cally non-excitable primary and cultured cells including Xenopus
oocytes (Demuro and Parker, 2013) astrocytes and PC12 cells
(Abramov et al., 2003, 2004a; Simakova and Arispe, 2006), our
data indicates that certain of the Ca2+ mobilizing properties of
Aβ42 are neuron-independent and do not require the expression
of any other of its reported targets. Fundamental aspects of the
Ca2+ mobilizing properties of Aβ42 were further revealed and
exemplified by the Aβ42 -stimulated Ca2+ flux from the InsP3R-
deficient ER of permeabilized DT40 B-lymphocytes. These latter
data demonstrate for the first time that Aβ42 has the capacity
to directly induce Ca2+ flux from the ER. Given the importance
of the ER and InsP3Rs in neuronal functions, future studies will
be required to test whether InsP3Rs contribute to Aβ-mediated
neuronal pathology.
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Figure S1 | Validating the toxicity and conformation of Aβ42 oligomers. (A)
Assessment of toxicity of homogeneous Aβ preparations. Bar chart
illustrating the cytotoxic effects of Aβ42 preparations upon SH-SY5Y cells
determined using the MTT assay. Data is expressed as a percentage of
MTT reduced by test samples to the dead cell controls following 24-h
treatment with Aβ42 oligomers and scrambled Aβ at the respective
concentrations. (Bi) Schematic diagram illustrating the epitopes of Aβ42
recognized by the conformation dependent, anti-oligomer antibody, A11
(Kayed et al., 2003), and the sequence dependent, anti-amyloid antibody,
12F4 (Parvathy et al., 2001). (Bii,iii) Sensorgrams obtained from surface
plasmon resonance spectroscopy, as described (Maezawa et al., 2008). A
Biacore T-100, equipped with four flow cells on a sensor chip, was used
for these real-time binding studies. Biotinylated Aβ42was prepared by
mixing a 1:10 molar ratio of biotinylated and unbiotinylated Aβ42. In
preparation for the binding studies, Aβ42 was injected onto a streptavidin
chip at a concentration of 10μM to immobilize Aβ42by streptavidin-biotin
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coupling. The streptavidin chip of flow cell (Fc) 2 was partially (50%) and
of Fc-4 fully saturated (100%) with Aβ42 oligomers. As a control, the
surface of Fc-3 was partially saturated (50%) with Aβ42monomers.
Antibodies (Bii) A11 and (Biii) 12F4 were injected over the immobilized
Aβ42 of each flow cell at a concentration of 50μg/ml and 10μg/ml,
respectively. The injection of the anti-oligomer antibody, A11, was
followed by a regeneration step prior to injection of 12F4. The binding of
injected antibodies, present in the flow phase, to the immobilized
Aβ42was measured by response units (RU) elicited. All values were
corrected for the RU obtained from the reference cell, flow cell 1, which
was saturated with biotinylated Aβ42 only.
Figure S2 | Comparison of Ca2+ responses elicited by Aβ42 oligomers and
monomers in SH-SY5Y cells. (A) Imaging protocol employed to assess the
effects of homogeneous preparations of Aβ42 on the Ca2+ signaling
capacity of fluo-4-loaded SH-SY5Y cells. Cellular Ca2+ responses were
recorded by wide-field epifluorescence. The magnitude of Ca2+
responses elicited by 5μM Aβ42 monomers and oligomers and the
subsequent application of 100μM CCH is presented as (B) percentage of
responding cells, (C) peak amplitude and (D) integral of the response.
Soluble Aβ monomers and Aβ oligomers were prepared as previously
described (Demuro et al., 2005). This method of Aβ preparation reportedly
results in homogeneous populations of Aβ monomers and oligomers (also
Figure S1B). All Aβ42 concentrations stated were based on the molar
mass of the peptide.
Figure S3 | Human neuroblastoma SH-SY5Y cells lack RyR expression. (A)
Representative Ca2+ trace illustrating that SH-SY5Y cells do not elicit
Ca2+ responses following the application of 10mM caffeine, indicating
that cells lack RyRs (n = 239 cells). However, SH-SY5Y cells do exhibit
InsP3-mediated Ca2+ responses. (B) Immunoblot analysis corroborating
the lack of RyR2 expression in SH-SY5Y cells. RyR2 expression is
observed in control samples of adult hippocampal tissue and primary
hippocampal cultures maintained for 4, 8, 11, and 15 days in vitro (DIVs).
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